🇺🇸 FDA
Pipeline program

PACLITAXEL, PF-08634404, SODIUM CHLORIDE, PACLITAXEL ALBUMIN-BOUND, PEMBROLIZUMAB, CARBOPLATIN, PEMETREXED

C6461001

Phase 3 small_molecule active

Quick answer

PACLITAXEL, PF-08634404, SODIUM CHLORIDE, PACLITAXEL ALBUMIN-BOUND, PEMBROLIZUMAB, CARBOPLATIN, PEMETREXED for LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER is a Phase 3 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer Ireland Pharmaceuticals Unlimited Company
Indication
LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials